Alfuzosin hydrochloride
Alfuzosin Hydrochloride is a prescription medication used to treat symptoms of benign prostatic hyperplasia (BPH), such as difficulty urinating. It comes as a 10 mg extended-release oral tablet, manufactured by Apotex Corp. under application ANDA079013. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Alfuzosin Hydrochloride is a prescription medication used to treat symptoms of benign prostatic hyperplasia (BPH), such as difficulty urinating. It comes as a 10 mg extended-release oral tablet, manufactured by Apotex Corp. under application ANDA079013. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Alfuzosin hydrochloride",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Alfuzosin hydrochloride — ANDA 203192 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203192"
}
]
|
| identifier | ANDA203192 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-manufacturers",
"health-care",
"medications"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Alfuzosin hydrochloride |
